title: Multimodal predictive modeling of individual treatment outcome in cocaine dependence with combined neuroimaging and behavioral predictors.
abstract: BACKGROUND
  Developing personalized treatments for cocaine dependence remains a significant clinical challenge. Positron emission tomography (PET) has shown that the [(11)C]raclopride signal in the ventral striatum is associated with treatment success in a positively reinforced contingency management program. The present study investigates whether this signal can be used to predict treatment outcome at an individual level.
  
  
  METHODS
  Predictive models were developed using PET signals from 5 regions of the striatum and follow-up data in 24 patients, and evaluated using cross-validation.
  
  
  RESULTS
  The ventral striatal PET signal alone can predict individual treatment response with a substantial degree of accuracy (cross-validated correct rate=82%). Incorporating information from other regions-of-interest (ROIs) in the striatum does not improve predictive performance, except for a small improvement with adding the posterior caudate. The addition of baseline demographic variables, including baseline severity measures, does not improve predictive performance. On the other hand, early treatment response and motivation, reflected by cumulative clinic attendance, performs as well as the PET signal (83%) by week 3 in the 24-week study. The combined model with both PET signals and cumulative clinic attendance demonstrates a significant improvement of performance, peaking at 96% during week 3 of the trial.
  
  
  CONCLUSIONS
  These results suggest that a multimodal model can predict treatment success in cocaine dependence at an individual level, and pose hypotheses for the underlying neural circuitry mechanisms responsible for individual variations in treatment outcome.
authors.affiliation: Division of Substance Abuse, Department of Psychiatry, New York State Psychiatric Institute, Columbia University, Box 83, 1051 Riverside Drive, New York, NY 10032, USA. Electronic address: xsl2101@columbia.edu.
authors.forename: Sean X
authors.initials: SX
authors.lastname: Luo
authors.affiliation: Division of Substance Abuse, Department of Psychiatry, New York State Psychiatric Institute, Columbia University, Box 83, 1051 Riverside Drive, New York, NY 10032, USA.
authors.forename: Diana
authors.initials: D
authors.lastname: Martinez
authors.affiliation: Division of Substance Abuse, Department of Psychiatry, New York State Psychiatric Institute, Columbia University, Box 83, 1051 Riverside Drive, New York, NY 10032, USA.
authors.forename: Kenneth M
authors.initials: KM
authors.lastname: Carpenter
authors.affiliation: Division of Substance Abuse, Department of Psychiatry, New York State Psychiatric Institute, Columbia University, Box 83, 1051 Riverside Drive, New York, NY 10032, USA.
authors.forename: Mark
authors.initials: M
authors.lastname: Slifstein
authors.affiliation: Division of Substance Abuse, Department of Psychiatry, New York State Psychiatric Institute, Columbia University, Box 83, 1051 Riverside Drive, New York, NY 10032, USA.
authors.forename: Edward V
authors.initials: EV
authors.lastname: Nunes
mesh_terms: D000328:Adult; D001521:Behavior Therapy; D019970:Cocaine-Related Disorders / Q000503:physiopathology / Q000523:psychology* / Q000628:therapy*; D003342:Corpus Striatum / Q000000981:diagnostic imaging / Q000502:physiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D059906:Neuroimaging; D010349:Patient Compliance; D049268:Positron-Emission Tomography; D057285:Precision Medicine / Q000379:methods* / Q000523:psychology; D011237:Predictive Value of Tests; D020891:Raclopride; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D020891:Raclopride
keywords: Cocaine; Dopamine; PET; Personalized medicine; Predictive modeling; Ventral striatum
references.citation: Exp Clin Psychopharmacol. 2012 Oct;20(5):430-5
references.pmid: 22867036
references.citation: Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2569-74
references.pmid: 9122236
references.citation: Neuropharmacology. 2010 Jun;58(7):951-61
references.pmid: 20096294
references.citation: J Cereb Blood Flow Metab. 2000 Mar;20(3):423-51
references.pmid: 10724107
references.citation: Biol Psychiatry. 2012 Dec 1;72(11):950-6
references.pmid: 22795453
references.citation: Trends Neurosci. 2008 Nov;31(11):552-8
references.pmid: 18786735
references.citation: J Subst Abuse Treat. 2006 Jun;30(4):291-5
references.pmid: 16716843
references.citation: Am J Drug Alcohol Abuse. 2007;33(2):191-206
references.pmid: 17497542
references.citation: Am J Psychiatry. 2005 Aug;162(8):1515-20
references.pmid: 16055774
references.citation: Addict Behav. 2007 Feb;32(2):370-6
references.pmid: 16713126
references.citation: Mol Psychiatry. 2012 Sep;17(9):918-25
references.pmid: 21747399
references.citation: Trends Cogn Sci. 2012 Jan;16(1):72-80
references.pmid: 22177032
references.citation: Nat Rev Neurosci. 2013 May;14(5):365-76
references.pmid: 23571845
references.citation: Neuroimage. 2012 Jul 16;61(4):1300-10
references.pmid: 22521475
references.citation: Front Psychiatry. 2012 Aug 30;3:77
references.pmid: 22969732
references.citation: Drug Alcohol Depend. 2007 May 11;88(2-3):214-23
references.pmid: 17134849
references.citation: Drug Alcohol Depend. 1996 May;41(1):25-33
references.pmid: 8793307
references.citation: Am J Psychiatry. 2009 Oct;166(10):1170-7
references.pmid: 19723785
references.citation: Neuroimage. 2012 Jan 16;59(2):895-907
references.pmid: 21992749
references.citation: Arch Gen Psychiatry. 2006 Feb;63(2):219-28
references.pmid: 16461866
references.citation: J Neurosci. 2009 Apr 15;29(15):4690-6
references.pmid: 19369539
references.citation: J Neurochem. 2001 Sep;78(5):1094-103
references.pmid: 11553683
references.citation: Drug Alcohol Depend. 2005 Jan 7;77(1):7-11
references.pmid: 15607836
references.citation: J Neurosci. 2010 Jun 2;30(22):7749-53
references.pmid: 20519550
references.citation: Arch Gen Psychiatry. 2003 Oct;60(10):1043-52
references.pmid: 14557150
references.citation: Drug Alcohol Depend. 2006 Feb 28;81(3):267-74
references.pmid: 16169160
references.citation: Annu Rev Neurosci. 2007;30:259-88
references.pmid: 17600522
references.citation: Am J Psychiatry. 2007 Apr;164(4):622-9
references.pmid: 17403976
references.citation: Science. 2005 Mar 11;307(5715):1642-5
references.pmid: 15761155
references.citation: J Cereb Blood Flow Metab. 2003 Mar;23(3):285-300
references.pmid: 12621304
references.citation: Synapse. 1994 Apr;16(4):255-62
references.pmid: 8059335
references.citation: Neuropharmacology. 2009;56 Suppl 1:3-8
references.pmid: 18617195
references.citation: Drug Alcohol Depend. 1996 Mar;40(3):195-201
references.pmid: 8861397
references.citation: Am J Psychiatry. 2004 Oct;161(10):1783-9
references.pmid: 15465974
references.citation: Am J Psychiatry. 2011 Jun;168(6):634-41
references.pmid: 21406463
references.citation: Hum Brain Mapp. 2012 Sep;33(9):2104-24
references.pmid: 22887825
references.citation: Drug Alcohol Depend. 2010 Sep 1;111(1-2):97-104
references.pmid: 20537812
references.citation: Neuroimage. 2013 Nov 1;81:499-502
references.pmid: 23587691
references.citation: Neuron. 2012 Jan 12;73(1):8-22
references.pmid: 22243743
references.citation: Psychol Addict Behav. 2001 Mar;15(1):52-9
references.pmid: 11255939
references.citation: Neuropsychopharmacology. 2009 Jun;34(7):1774-82
references.pmid: 19177067
references.citation: PLoS One. 2012;7(7):e40968
references.pmid: 22815880
references.citation: Nature. 1997 Apr 24;386(6627):830-3
references.pmid: 9126741
references.citation: NIDA Res Monogr. 1993;137:97-121
references.pmid: 8289930
references.citation: Arch Gen Psychiatry. 2009 Jul;66(7):700-12
references.pmid: 19581561